Aparajita Lath

Aparajita graduated from the National University of Juridical Sciences, Kolkata where she was on the Board of Editors of the NUJS Law Review. She has worked at AZB & Partners and Trilegal. She is currently pursuing her LL.M at Harvard Law School and is a Student Fellow at the Petrie-Flom Centre.

Others

Guest Post: IP conferences, judges & ethics: A presumption of bias?

by
1 Comment

Prashant Reddy has for our readers a very well worded post which addresses the issue of the general perception that judges may become bias after attending industry sponsored conferences, in a very perceptive manner. His observation of this issue provides an alternate view to an earlier post on the same issue here. Prashant is an independent IP consultant. He was an integral part of SpicyIP for many years and is a prolific writer! IP Conferences, judges & ethics: A presumption of…


Read More »
Trademark

Guest Post: Delhi HC: Officer’s Special and Collector’s Choice Deceptively Similar to Officer’s Choice

by
Leave a Comment

 We have for our readers a guest post by Ritvik Kulkarni. Ritvik is a third year law student, studying at ILS, Pune. He has written for us previously here.  Delhi HC: Officer’s Special and Collector’s Choice Deceptively Similar to Officer’s Choice    By Ritvik Kulkarni  In the battle brewing between whiskey manufactures, the proprietor of the mark “Officer’s Choice” has emerged a victorious. The Delhi High Court has vide its order dated 6th July 2015 dismissed the appeals of the proprietors…


Read More »
Patent

Guest Post: The Delhi High Court has its Hands Tied: Writ Concerning Divisional Patent Applications

by
Leave a Comment

We have for our readers a guest post by Ritvik Kulkarni. Ritvik is a third year law student, studying at ILS, Pune. In this blog post he examines a recent writ petition filed by the Delhi Network of Positive People (DNPP) in relation to the abusive practice of filing divisional patent applications and their impact on access to medicine.   The Delhi High Court has its Hands Tied: Writ Concerning Divisional Patent Applications By Ritvik Kulkarni Recently, through a writ petition before the Delhi…


Read More »
Trademark

VIT University Trademark Dispute: A rose is a rose?

by
Leave a Comment

Recently, the Madras High Court granted an interim injunction restraining Vivekananda Institute of Technology from using the acronym ‘VIT’ in relation to its engineering colleges. Since Vellore Institute of Technology, Vellore, was the prior registered owner of the mark VIT for education, training, sports etc, and the mark was held to be a well known mark, the question the court had to decide was whether the defendant could be allowed to ‘VIT’ for their educational institutions set up in Jaipur….


Read More »
Patent

Eureka Forbes and Hindustan Unilever: Water purification patent pitter-patter

by
1 Comment

A few days ago, as reported by the Financial Express, the Chennai patent office rejected a patent application filed by Eureka Forbes for its ‘iron removal water purifier’ after a pre grant opposition filed by Hindustan Unilever Ltd. Hindustan Unilever argued that “the usage of ion exchange resin for the removal of iron as well as its usage in gravity water filters is well known in prior art.” Moreover, as reported, Hindustan Unilever contended that Eureka Forbes had failed to…


Read More »
Geographical Indication

Who is going to be the G.I. Joe that will save the vanishing Indian GIs?

by
5 Comments

A few days ago the Hindu published a telling editorial written by Justice Prabha Sridevan, former judge of the Madras High Court and former Chairperson of the IPAB. The lucid editorial highlights the need for India to concentrate not just on patents and other mainstream IP rights but also bring back Geographical Indications (GIs) into the foreground of debate. This is specially true for India, as she rightly remarks “Practically everything that we grow, make or produce is linked to…


Read More »
Others

SpicyIP Tidbit: Indian Pharmaceutical Alliance launches a new website

by
5 Comments

The Indian Pharmaceutical Alliance (IPA) that represents researched based national pharmaceutical companies recently launched its website: www.ipa-india.org. As Mr. D G Shah, Secretary General, IPA states “The website provides plenty of information and data on diverse subjects.  Be it pricing, patents, drug regulatory regime or role and contribution of the national pharmaceutical industry to the economy.  It shares IPA presentations at various fora and position papers on many subjects.  Its rich content will help you to source various information related…


Read More »
Trademark

SpicyIP Tidbit: HUL proposes inclusion of IPR in school syllabus

by
5 Comments

“I don’t understand maths. But still, I made an effort to wake up at 5.30 a.m. every morning to solve maths problems, but to no use. I feel these problems are not at all relevant and useful”, a high school student in Karnataka frankly admitted this in his SSLC answer sheet, as reported yesterday in the Hindu. Various other answers such as chicken curry recipes, heartfelt appeals for pass marks are also apparently common place in math exams. Though these…


Read More »
Patent

Teva v. Natco : Copaxone litigation update

by
6 Comments

In 2007, Teva and others filed CS (OS) No. 1708 of 2007 against Natco before the Delhi High Court seeking a permanent injunction in order to restrain Natco from infringing Teva’s Indian Patent No.190759. The prayer also asked the court for an order to restrain Natco from exporting infringing drugs outside India. The patent is a process patent for producing Glatiramer Acetate (also known as Copolymer 1 or ‘Copaxone’ as marketed by Teva). Copaxone is used for the treatment of…


Read More »
Patent

Guest Post: A ‘captured’ Commerce Ministry puts profits before the safety of ‘Made in India’ medicines

by
Leave a Comment

Prashant Reddy has for our readers a telling post that opens a can of worms as it throws light on the goings-on in the drug regulatory arena in India. Prashant is a lawyer who advises on IP & regulatory issues in the pharmaceutical sector. A ‘captured’ Commerce Ministry puts profits before the safety of ‘Made in India’ medicines  Prashant Reddy* In December, 2014 news broke of possible action by European drug regulators against GVK Biosciences over discrepancies in clinical trials that it had…


Read More »
  1. Pages:
  3. 1
  4. 2
  5. 3
  6. 4
  7. 5
  8. 6
  9. 7
  10. 8
  11. 9
  12. ...
  13. 16